Price target 5 $Analysts at HC Wainright lowered their price target on shares of RXi Pharmaceuticals Corp from $9.00 to $5.00 and set a buy rating on the stock in a research note on Tuesday, March 31st. They noted that the move was a valuation call.
https://www.wkrb13.com/markets/579238/rxi-pharmaceuticals-corp-given-buy-rating-at-zacks-rxii/